BLOOMBERG On The Move With Rishaad Salamat April 7, 2014
Aat better way to launch with 4 billion deal in the generic drugs industry. John is here with the details. We are talking about ranbaxy. Thats right. Clearly, shares were rising in that region, but sun pharma agreed to by ranbaxy at 4. 1 billion. Here,sting, the movement the Japanese Company owning a large part of ranbaxy. It is a done deal essentially . Yes. In 2008, the Company Bought ranbaxy for for for 1 billion. With u. S. Ssues authorities. It has been a problem child. Ranbaxy, for plans t...
Source: archive.org